If you are wondering whether Novavax at around US$7.25 is a bargain or a value trap, you are not alone. This article focuses on what the current price really implies about the company. The stock has ...

Shares of vaccine biotechnology company Novavax (NASDAQ:NVAX) jumped 3% in the morning session after reports revealed that its JN.1 Covid-19 vaccine became available at some GP clinics in Singapore.

Vaccine biotechnology company Novavax (NASDAQ:NVAX) beat Wall Street’s revenue expectations in Q3 CY2025, but sales fell by ...

Looking back on therapeutics stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Novavax ...

The Centers for Disease Control and Prevention (CDC) on Monday announced dramatic changes to the U.S. childhood vaccine ...

The FDA has played an active role in US Health Secretary Robert F. Kennedy Jr.’s agenda to scrutinize vaccines, even if the ...

The new U.S. guidelines recommend all children get vaccines for 11 diseases, compared with the 18, including Covid, ...

Let’s be clear. The primary reason to be vaccinated against shingles is that two shots provide 90 percent protection against ...

The US FDA approved 46 new drugs in 2025, despite a tumultuous year at the regulatory agency.

In turn, the company—which is broadly seeking to develop inflammatory drugs targeting the complement system—anticipates ...